Subsys - Providence Business News

Home Tags Subsys

Insys files for bankruptcy, overcome by opioid liabilities

Government 06/10/2019

NEW YORK – Insys Therapeutics Inc. filed for bankruptcy protection after agreeing to pay hundreds of millions of dollars to settle a related probe...

DR. JERROLD N. ROSENBERG, 63, former operator of a now-defunct pain-management practice in Rhode Island, was sentenced in U.S. District Court March 9 to four years in prison for conspiring to solicit and receive kickbacks through his prescribing of the drug Subsys. / COURTESY JRMD.NET

Rosenberg sentenced to 4 years for Subsys prescription scam

Government 03/09/2018

PROVIDENCE – Dr. Jerrold N. Rosenberg, 62, of North Providence, was sentenced by U.S. District Court Judge John J. McConnell Jr. Friday to four...

DR. JERROLD N. ROSENBERG, 63, operator of a now-defunct pain management practice in Rhode Island, pleaded guilty in U.S. District Court Oct. 25 to conspiring to solicit and receive kickbacks through his prescribing of the drug Subsys. / COURTESY JRMD.NET

Rosenberg pleads guilty to fraud, kickback conspiracy in Subsys prescription scam

Government 10/25/2017

PROVIDENCE - Jerrold N. Rosenberg, 62, of North Providence, indicted in U.S. District Court in February on health care fraud and conspiring to solicit and...

- Featured Event -

Latest News

CVS to cut additional 111 jobs in R.I.

12/08/2023

Providence City Council updates zoning rules to streamline housing development

12/08/2023

STATE AND LOCAL OFFICIALS and students at Frank D. Spaziano Elementary School in Providence cut the ribbon Friday on the new $44 million school building. / COURTESY PROVIDENCE PUBLIC SCHOOL DISTRICT

Officials cut ribbon on new Spaziano Elementary School in Providence

12/08/2023

Report: Newport County top in U.S. for second-home purchases

12/08/2023

Judge seeks disciplinary action against Neronha

12/08/2023

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.